Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.1%

10 terminated/withdrawn out of 484 trials

Success Rate

93.1%

+6.6% vs industry average

Late-Stage Pipeline

9%

45 trials in Phase 3/4

Results Transparency

11%

15 of 135 completed trials have results

Key Signals

87 recruiting15 with results7 terminated

Enrollment Performance

Analytics

N/A
210(65.8%)
Phase 2
35(11.0%)
Phase 3
25(7.8%)
Phase 1
21(6.6%)
Phase 4
20(6.3%)
Early Phase 1
8(2.5%)
319Total
N/A(210)
Phase 2(35)
Phase 3(25)
Phase 1(21)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (484)

Showing 20 of 484 trials
NCT06509919Suspended

Application of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection of Prostate Cancer

Role: collaborator

NCT06589154Completed

The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis

Role: collaborator

NCT03324698Active Not Recruiting

The Natural History of Chronic Pancreatitis

Role: lead

NCT06963112Phase 1Completed

Intraoperative Midazolam on Delirium Outcome of Elderly Patients

Role: collaborator

NCT07622199Not ApplicableRecruiting

PROfunda Femoris Vein Thrombosis Evaluation and Clearance to Improve Outcomes of Endovascular Treatment for Acute Iliofemoral Deep Vein Thrombosis

Role: collaborator

NCT07307456Phase 2Recruiting

Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration

Role: lead

NCT07672210Recruiting

PregnAncy-Related Aortic DISsEction in China

Role: collaborator

NCT06728826Not ApplicableRecruiting

Prevention of Atrial Fibrillation After Cardiac Surgery by Pericardiotomy

Role: lead

NCT07036991Recruiting

A Cohort Study Comparing PCSK9 Inhibitor Plus Statin With Statin Monotherapy for Carotid Artery Stenosis

Role: lead

NCT07691593Phase 2Not Yet Recruiting

Neoadjuvant HRS-4642 Plus Chemotherapy With or Without Immunotherapy for Pancreatic Cancer

Role: lead

NCT06352619Not ApplicableRecruiting

Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial

Role: collaborator

NCT04967560Not ApplicableCompleted

The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD

Role: collaborator

NCT07678788Not Yet Recruiting

Study on the Association Between Serrated Polyps and Metachronous Advanced Colorectal Neoplastic Lesions

Role: lead

NCT06469190Early Phase 1Recruiting

An Exploratory Clinical Study of Anti-CD19 CAR NK Cell (KN5501) in the Treatment of Relapsed/Refractory Immune Nephropathy

Role: lead

NCT06263205Not ApplicableCompleted

Non-Dressing vs. Routine Dressing Change After Gastrointestinal Cancer Surgery

Role: collaborator

NCT05289362Not ApplicableCompleted

Comparison of Efficacy of Basket and Balloon in the Removal of Pancreatic Duct Stones in Chronic Pancreatitis Under ERCP

Role: lead

NCT05384444Not ApplicableActive Not Recruiting

Effect of FMD on Colorectal Cancer Patients

Role: collaborator

NCT05326932Not ApplicableRecruiting

Large Artery Occlusion Treated in Extended Time With Mechanical Thrombectomy Trial

Role: collaborator

NCT06158516Phase 2Terminated

A Study of Surufatinib as Adjuvant Therapy for Pancreatic Neuroendocrine Tumors

Role: lead

NCT07452406Not ApplicableNot Yet Recruiting

Protocolized Weaning of High-Flow Nasal Cannula in Adult Patients

Role: collaborator